Icon Wealth Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $993K | Sell |
2,647
-404
| -13% | -$152K | 0.11% | 120 |
|
|
2023
Q2 | $1.17M | Sell |
3,051
-430
| -12% | -$164K | 0.12% | 123 |
|
|
2023
Q1 | $1.21M | Buy |
+3,481
| New | +$1.21M | 0.13% | 124 |
|
|
2022
Q2 | $1.03M | Sell |
3,390
-826
| -20% | -$250K | 0.12% | 132 |
|
|
2022
Q1 | $1.73M | Sell |
4,216
-1,301
| -24% | -$534K | 0.17% | 105 |
|
|
2021
Q4 | $2.59M | Buy |
5,517
+26
| +0.5% | +$12.2K | 0.26% | 90 |
|
|
2021
Q3 | $2.33M | Buy |
5,491
+262
| +5% | +$111K | 0.25% | 96 |
|
|
2021
Q2 | $1.88M | Buy |
5,229
+629
| +14% | +$226K | 0.2% | 107 |
|
|
2021
Q1 | $1.3M | Buy |
4,600
+1,030
| +29% | +$290K | 0.16% | 121 |
|
|
2020
Q4 | $1.01M | Buy |
3,570
+729
| +26% | +$206K | 0.16% | 117 |
|
|
2020
Q3 | $781K | Buy |
+2,841
| New | +$781K | 0.15% | 112 |
|
|
2019
Q2 | – | Sell |
-417
| Closed | -$46K | – | 782 |
|
|
2019
Q1 | $46K | Buy |
+417
| New | +$46K | 0.02% | 372 |
|
|
2018
Q3 | – | Sell |
-316
| Closed | -$31K | – | 728 |
|
|
2018
Q2 | $31K | Buy |
+316
| New | +$31K | 0.01% | 490 |
|
|
2018
Q1 | – | Sell |
-316
| Closed | -$31K | – | 739 |
|
|
2017
Q4 | $31K | Buy |
+316
| New | +$31K | 0.02% | 522 |
|